Literature DB >> 16438798

ROS as signalling molecules in T cells--evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis.

Helen R Griffiths1.   

Abstract

Reactive oxygen species are recognised as important signalling molecules within cells of the immune system. This is, at least in part, due to the reversible activation of kinases, phosphatases and transcription factors by modification of critical thiol residues. However, in the chronic inflammatory disease rheumatoid arthritis, cells of the immune system are exposed to increased levels of oxidative stress and the T cell becomes refractory to growth and death stimuli. This contributes to the perpetuation of the immune response. As many of the effective therapies used in the treatment of rheumatoid arthritis modulate intracellular redox state, this raises the question of whether increased oxidative stress is causative of T-cell hyporesponsiveness. To address this hypothesis, this review considers the putative sources of ROS involved in normal intracellular signalling in T cells and the evidence in support of abnormal ROS fluxes contributing to T-cell hyporesponsiveness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16438798     DOI: 10.1179/135100005X83680

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  39 in total

Review 1.  Contributions to our understanding of T cell physiology through unveiling the T cell proteome.

Authors:  M M Grant; D Scheel-Toellner; H R Griffiths
Journal:  Clin Exp Immunol       Date:  2007-05-04       Impact factor: 4.330

2.  Oxidative mechanisms and atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Drug Discov Today Ther Strateg       Date:  2008-03

3.  Copper-zinc superoxide dismutase-deficient mice show increased susceptibility to experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein 35-55.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Heejeong Kim; Charlotte Stanford; Govardhan Rathnaiah; David Steffen; Jaekwon Lee; Jay Reddy
Journal:  J Neuroimmunol       Date:  2013-01-05       Impact factor: 3.478

Review 4.  Mitochondrial targeting of electron scavenging antioxidants: Regulation of selective oxidation vs random chain reactions.

Authors:  Valerian E Kagan; Peter Wipf; Detcho Stoyanovsky; Joel S Greenberger; Grigory Borisenko; Natalia A Belikova; Naveena Yanamala; Alejandro K Samhan Arias; Muhammad A Tungekar; Jianfei Jiang; Yulia Y Tyurina; Jing Ji; Judith Klein-Seetharaman; Bruce R Pitt; Anna A Shvedova; Hülya Bayir
Journal:  Adv Drug Deliv Rev       Date:  2009-08-27       Impact factor: 15.470

5.  Gingipains from Porphyromonas gingivalis increase the chemotactic and respiratory burst-priming properties of the 77-amino-acid interleukin-8 variant.

Authors:  Irundika H K Dias; Lindsay Marshall; Peter A Lambert; Iain L C Chapple; John B Matthews; Helen R Griffiths
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

6.  Reduced mitochondrial SOD displays mortality characteristics reminiscent of natural aging.

Authors:  Anirban Paul; Amy Belton; Sanjay Nag; Ian Martin; Michael S Grotewiel; Atanu Duttaroy
Journal:  Mech Ageing Dev       Date:  2007-11-04       Impact factor: 5.432

Review 7.  Redox signalling and the inflammatory response in rheumatoid arthritis.

Authors:  L I Filippin; R Vercelino; N P Marroni; R M Xavier
Journal:  Clin Exp Immunol       Date:  2008-04-16       Impact factor: 4.330

Review 8.  Oxidative risk for atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

9.  Cytochrome-P450 enzymes and autoimmunity: expansion of the relationship and introduction of free radicals as the link.

Authors:  M R Namazi
Journal:  J Autoimmune Dis       Date:  2009-06-25

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.